FDA publishes an updated final guidance on the Breakthrough Device program.
FDA grants Attune Medical a de novo marketing authorization for its ensoETM device and its use to reduce the likelihood of ablation-related esophageal...
Federal Register notice: FDA establishes a docket to solicit stakeholder comments to assist the agency in developing a Quality Management Maturity pro...
FDA says exploring how artificial intelligence can play a role in its regulatory operations is a top strategic goal of its just-released four-year inf...
FDA publishes draft guidances to support clinical and non-clinical testing in premarket submissions for medical devices with a weight loss indication.
The Federal Trade Commission issues a policy statement, which is supported by FDA, warning brand-name pharmaceutical companies that they could face le...
FDA approves updated and revised labeling for Mercks Temodar under the Oncology Center of Excellence Project Renewal pilot program.